B6.Cg-Igs2tm1(ITGA11-cre)Dgul/Oulu

Status

Available to order

EMMA IDEM:13227
International strain nameB6.Cg-Igs2tm1(ITGA11-cre)Dgul/Oulu
Alternative nameB6.Cg-Tg(ITGA11-Cre)Dgul
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolIgs2tm1(ITGA11-cre)Dgul,
Gene/Transgene symbolIgs2

Information from provider

ProviderDonald Gullberg
Provider affiliationUniversity of Bergen
Genetic informationThis strain was generated by the site-specific integrase-mediated transgenesis where the transgene (ITGA11-cre) was site-specifically inserted/integrated into a pre-modified Igs2 (or Hipp11) locus of the mouse genome, via pronuclear injection. The mutant mice carry the ITGA11-cre transgene where the cre recombinase expression is driven by the human integrin alpha11 promoter (plasmid construct: pBT378.3-ITGA11-Cre; 3 kb fragment of ITGA11 promoter). Characterization of the strain indicates fibroblast-specific expression of cre recombinase, during development and fibrosis, which resembles the endogenous integrin alpha 11 expression and regulation pattern. These mutant mice can be useful in studies involving fibroblasts, like analysis of different types of fibrosis and tumor cells-fibroblasts interactions.
Phenotypic informationHomozygous:
No observable phenotypic changes with homozygous transgenic mice.

Heterozygous:
No observable phenotypic changes with the hemizygous transgenic mice.
Breeding historyThe F0 mice were generated in 2014 in Transgenic Core Facility at Stanford University and F1 mice were imported to our Animal Facility at University of Bergen in 2015. After arrival, the mice have been rederived and backcrossed to wild-type C57BL/6J mice and later kept as inbred. The mutant mice have been bred as both hemizygotes and homozygotes during the breeding period. The strain may need to be refreshed by backcrossing again to wild-type C57BL/6J mice to recover from potential genetic drift.
References
  • Generation of a novel mouse strain with fibroblast-specific expression of Cre recombinase.;Alam Jahedul, Musiime Moses, Romaine Andreas, Sawant Mugdha, Melleby Arne Olav, Lu Ning, Eckes Beate, Christensen Geir, Gullberg Donald, ;2020;Matrix biology plus;8;100045; 33543038
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland
Animals used for archivingheterozygous C57BL/6NCrl, wild-type C57BL/6NCrl
Stage of embryos2-cell

Literature references

  • Generation of a novel mouse strain with fibroblast-specific expression of Cre recombinase.;Alam Jahedul, Musiime Moses, Romaine Andreas, Sawant Mugdha, Melleby Arne Olav, Lu Ning, Eckes Beate, Christensen Geir, Gullberg Donald, ;2020;Matrix biology plus;8;100045; 33543038

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).